| Identification | Back Directory | [Name]
ML 23 | [CAS]
108929-03-9 | [Synonyms]
ML 23
N-(3,5-Dinitrophenyl)-5-methoxy-1H-indole-3-ethanamine
N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-2,4-dinitroaniline | [Molecular Formula]
C17H16N4O5 | [MOL File]
108929-03-9.mol |
| Hazard Information | Back Directory | [Description]
ML 23 is a melatonin analogue in the treatment and management of Parkinson's disease. ML-23 is a potential clinical candidate for the treatment of PD, and the present study has been undertaken to determine the efficacy of ML-23 in the 1-methyl-4-phenyl, 1,2,3,6 tetrahydropyridine (MPTP) model in the common marmoset. On all parameters, ML-23 produced a significant remission from MPTP-induced Parkinsonism, and this effect did not abate when ML-23 treatment was withdrawn. Conversely, a recurrence of Parkinsonian signs was not observed when ML-23 treatment was withdrawn and substituted with oral vehicle. |
|
| Company Name: |
BOC Sciences
|
| Tel: |
16314854226 |
| Website: |
www.bocsci.com |
|